FY2026 (April 1, 2025 - March 31, 2026)

(Millions of Yen)

Takara Holdings

Inc.

(Consolidated)

y-o-

y(%)

Takara

Shuzo

y-o-

y(%)

Takara

Shuzo

International

Group

y-o-

y(%)

Takara

Bio

Group

y-o-

y(%)

Sales to customer

394,316

108.7%

119,122

99.5%

221,888

119.4%

40,318

89.5%

Cost of sales

266,620

109.7%

88,948

99.1%

149,075

118.2%

20,057

105.7%

Gross profit

127,696

106.7%

30,174

100.9%

72,812

122.0%

20,261

77.7%

SG&A expenses

110,619

111.7%

24,445

98.2%

58,610

122.0%

24,949

104.8%

Operating income

17,076

82.9%

5,729

113.7%

14,201

121.8%

▲4,688

-

Non-operating

income

2,400

80.6%

402

89.6%

731

56.7%

427

69.1%

Non-operating

expenses

2,615

187.5%

455

145.8%

1,487

159.1%

732

252.8%

Ordinary income

16,861

76.0%

5,676

109.7%

13,445

112.0%

▲4,992

-

Extraordinary gain

7,392

156.1%

162

23.4%

43

216.4%

112

-

Extraordinary loss

5,983

544.4%

738

170.0%

162

273.2%

4,319

717.8%

Income before

income taxes and

minority interests

18,270

70.8%

5,100

93.8%

13,326

111.3%

▲9,200

-

Net income

attributable to

owners of the parent

11,696

72.2%

3,516

93.4%

8,082

108.1%

▲9,599

-

――――

――――

――――

――――

――――

――――

――――

――――

――――

Research and

development

expenses

7,247

99.1%

430

107.6%

0

-

6,806

98.7%

Capital

expenditures

24,500

117.9%

4,198

101.5%

4,869

109.4%

12,500

123.7%

Depreciation

12,225

118.1%

3,029

109.2%

4,672

132.7%

4,136

114.5%

Amortization of

goodwill

3,129

181.2%

0

-

2,112

203.7%

1,017

147.3%